BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35093384)

  • 1. Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation.
    Medeiros PJ; Pascetta SA; Kirsh SM; Al-Khazraji BK; Uniacke J
    J Biol Chem; 2022 Mar; 298(3):101645. PubMed ID: 35093384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling.
    Pascetta SA; Kirsh SM; Cameron M; Uniacke J
    BMC Cancer; 2023 Jun; 23(1):494. PubMed ID: 37264315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
    Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
    Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression.
    Raposinho PD; Pedrazzini T; White RB; Palmiter RD; Aubert ML
    Endocrinology; 2004 Jan; 145(1):304-10. PubMed ID: 14525913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
    Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
    Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y promotes hepatic apolipoprotein A1 synthesis and secretion through neuropeptide Y Y5 receptor.
    Liu B; Chen F
    Peptides; 2022 Aug; 154():170824. PubMed ID: 35660638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
    Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
    Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
    Lu C; Mahajan A; Hong SH; Galli S; Zhu S; Tilan JU; Abualsaud N; Adnani M; Chung S; Elmansy N; Rodgers J; Rodriguez O; Albanese C; Wang H; Regan M; Zgonc V; Blancato J; Krawczyk E; Gallicano GI; Girgis M; Cheema A; Iżycka-Świeszewska E; Cavalli LR; Pack SD; Kitlinska J
    Nat Commun; 2022 Apr; 13(1):2323. PubMed ID: 35484119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y regulates proliferation and apoptosis in granulosa cells in a follicular stage-dependent manner.
    Urata Y; Salehi R; Lima PDA; Osuga Y; Tsang BK
    J Ovarian Res; 2020 Jan; 13(1):5. PubMed ID: 31915051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of gene expression in pig adipose tissue: insulin-like growth factor system proteins, neuropeptide Y (NPY), NPY receptors, neurotrophic factors and other secreted factors.
    Hausman GJ; Barb CR; Dean RG
    Domest Anim Endocrinol; 2008 Jul; 35(1):24-34. PubMed ID: 18325722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
    Medeiros PJ; Jackson DN
    Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
    Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
    PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
    Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
    Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity.
    Nie M; Selbie LA
    Regul Pept; 1998 Sep; 75-76():207-13. PubMed ID: 9802411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
    Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
    Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of incubation temperature on neuropeptide Y and neuropeptide Y receptors in turkey and chicken satellite cells.
    Clark DL; McCormick JL; Velleman SG
    Comp Biochem Physiol A Mol Integr Physiol; 2018 May; 219-220():58-66. PubMed ID: 29505887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
    Reubi JC; Gugger M; Waser B; Schaer JC
    Cancer Res; 2001 Jun; 61(11):4636-41. PubMed ID: 11389101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors.
    Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Fisher TA; Ji H
    Regul Pept; 1998 Sep; 75-76():231-8. PubMed ID: 9802414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.